CULLEN INVESTMENT GROUP, LTD.

Position in MRK — Merck & Co., Inc.

CIK 797203 LAFAYETTE, LA

Position in MRK

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$14,261,187

+$699,813 QoQ

Shares Held

110,982

-1.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

1.83%

of 13F equity value

Holder Rank

#620

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CULLEN INVESTMENT GROUP, LTD. holds $51,757,200 across 9 Drug Manufacturers - General names. MRK ranks #1 (27.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc. This page	110,982	$14,261,187
2	LLY	ELI LILLY & Co	11,647	$13,969,762
3	NVS	Novartis AG	55,534	$8,703,288
4	JNJ	Johnson & Johnson	24,881	$6,319,027
5	ABBV	AbbVie Inc.	12,865	$3,237,348
6	AMGN	Amgen Inc	7,730	$2,799,187
7	GILD	Gilead Sciences, Inc.	12,730	$1,608,308
8	NVO	Novo Nordisk A S	10,000	$479,400

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,261,187	110,982	-1.6%	Shares	Sole	2026-07-09
2026-03-31	$13,561,374	112,739	-4.2%	Shares	Sole	2026-04-09
2025-12-31	$12,380,996	117,623	-9.0%	Shares	Sole	2026-01-12
2025-09-30	$10,853,491	129,316	+7.4%	Shares	Sole	2025-10-07
2025-06-30	$9,532,922	120,426	+9.3%	Shares	Sole	2025-07-01
2025-03-31	$9,890,564	110,189	+12.4%	Shares	Sole	2025-04-01
2024-12-31	$9,755,108	98,061	+2.2%	Shares	Sole	2025-01-13
2024-09-30	$10,899,148	95,977	+3.3%	Shares	Sole	2024-10-04
2024-06-30	$11,506,095	92,941	+0.8%	Shares	Sole	2024-07-01
2024-03-31	$12,164,470	92,190	+3.0%	Shares	Sole	2024-04-04
2023-12-31	$9,762,195	89,545	—	Shares	Sole	2024-01-30
No filing history on record for this holder in this stock.